Veru crashes 65% as trading resumes after AdCom snub for COVID-19 therapy

Approval may bolster hopes for Regeneron’s COVID-19 therapy, which uses same strategy.

In a small study, researchers modified patients’ immune cells to target their particular cancer—but it only worked for a third of volunteers.

Republicans in the Wisconsin State Legislature earlier this month blocked a ban on conversion therapy, a pseudoscientific method of "curing" non-heteronormative sexual orientations and gender preferences, that is illegal in nearly half the country.On Thursday, January 12th, all six GOP lawmakers on the Joint Committee for Review and Administrative Rules banded together to strike down the Badger State's standing prohibition, "effectively making the practice legal," the Heartland Signal reported on Monday. It was the second time that conservative legislators relegalized the dehumanizing...

OPINION Some good news for a change -- adventure therapy brings hope and renewal.

Axsome in licensing pact with Pharmanovia for sleep disorder therapy Sunosi

Burnout in therapists and psychiatrists is not new, but there is something different with COVID-19. Therapists should be prioritizing themselves, too, or there is a risk of becoming depressed and...

BrainStorm plunges 76% as FDA declines marketing application for ALS therapy

Axsome to face payer headwinds as depression therapy launches BofA

Money collected will be used for regular therapy sessions

Horizon announces FDA label update for thyroid eye disease therapy

President’s championing of novel therapy thrusts biotech group into uncomfortable spotlight

Richard Binstein Sells 1,808 Shares of U.S. Physical Therapy, Inc. (NYSEUSPH) Stock

Some people who have long lived with the disease say they worry about living as a healthy person, while others worry about the obstacles to getting treatment.

U.S. Physical Therapy goes ex-dividend tomorrow

Primcyv is a targeted therapy containing the active constituent palbociclib

Eisai exec expects full approval of Alzheimer's therapy Leqembi this summer - CNBC

BrainStorm to seek FDA approval for ALS therapy despite Phase 3 setback

Retail therapy but make it practical

ViewRay MRI-guided radiation therapy selected by SUNY upstate cancer center

Independent Advisor Alliance Buys Shares of 57,090 ATI Physical Therapy, Inc. (NYSEATIP)

Amylyx in pact to commercialize ALS therapy in Israel

Alleviate your low mood with the help of light therapy, meditation and more

Money collected will be used for regular therapy sessions

DotCom Therapy, a pediatric teletherapy company, just closed a $13 million series A round. It’s far from the only teletherapy company looking to capitalize on a boom in venture capital investment in mental health startups, but it’s operating in a hyper-specific sphere therapy for kids.  DotCom The…

Immunocore Reports Initial Phase 1 Data for TCR Therapy

Determining when to seek therapy for your child or teenager might feel daunting. These experts provide clarity about when you might want to seek help.

Merck wins FDA priority review for label expansion of cytomegalovirus therapy

Napoli have confirmed that Victor Osimhen is still training separately and seems set to miss out against Inter this week.

Millions are eligible for the therapy but may not be aware it exists.

MONTREAL, Nov. 08, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today that its proprietary ECT-001 Cell Therapy has been administered to 100 patients. ECT-001 Cell Therapy is an investigational UM171-expanded cord blood cell therapy being evaluated in trials across multiple adult and pediatric hematological […]

AstraZeneca, Genertec Meheco ink deal for COVID therapy Evusheld in China

Axsome in licensing pact with Pharmanovia for sleep disorder therapy Sunosi

Retail therapy but make it practical

PTC Therapeutics gene therapy Upstaza for rare neuromuscular disorder gets approval in UK

Phoenix Physical Therapy and Messiah University will open a new outpatient clinic at Messiah University Thursday. The post Messiah U. and Phoenix Physical Therapy join forces  appeared first on Central Penn Business Journal.

(marketscreener.com) U.S. Physical Therapy, Inc. , a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced an acquisition of a two-clinic physical therapy practice.USPH acquired 80% of the equity interests of the physical therapy practice with the practice’s owners retaining 20%. The...https//www.marketscreener.com/quote/stock/U-S-PHYSICAL-THERAPY-IN-11268480/news/U-S-Physical-Therapy-Announces-Acquisition-Of-A-Two-Clinic-Physical-Therapy-Practice-41913873/?utm_medium=RSS&utm_content=20221003

Novo Nordisk says FDA updated label for oral diabetes therapy Rybelsus

MONTREAL, Nov. 08, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today that its proprietary ECT-001 Cell Therapy has been administered to 100 patients. ECT-001 Cell Therapy is an investigational UM171-expanded cord blood cell therapy being evaluated in trials across multiple adult and pediatric hematological […]

Short Interest in ATI Physical Therapy, Inc. (NYSEATIP) Decreases By 5.0%

Immunocore Reports Initial Phase 1 Data for TCR Therapy

Innovent wins China’s breakthrough therapy status for KRASG12C Inhibitor

Retail therapy but make it practical

Primcyv is a targeted therapy containing the active constituent palbociclib

Tonix Pharma rises on positive data from preclinical study of colorectal cancer therapy

Sage's therapy for Huntington's disease gets orphan drug status in EU

Certainly! In recent years, there has been a growing interest in using psychedelics such as psilocybin (the active ingredient in magic mushrooms) for therapeutic purposes. While it is technically illegal to possess or use these substances in Australia without a prescription, there are several organizations and individuals working towards legalizing and regulating their use for medical purposes.One of the main drivers behind this movement is the potential benefits that psychedelics may have in treating anxiety disorders. Research has shown that psilocybin can reduce symptoms of anxiety and depression, as well as improve overall mental health. In fact, a study published in the Journal of Psychopharmacology found that a single dose of psilocybin was effective in reducing symptoms of social anxiety disorder in healthy individuals.Despite these potential benefits, there are still many challenges to overcome before psychedelics can be widely used as a treatment for anxiety and other mental health conditions. One of the main obstacles is the lack of research on the long-term effects of psilocybin use, as well as the potential risks associated with its use. Additionally, there are concerns about the regulation and accessibility of these substances, particularly for those who may not have access to medical professionals or specialized treatment facilities.Overall, while there is still much work to be done in fully understanding the potential benefits and risks of psilocybin use, it is clear that this substance has the potential to revolutionize the way we approach mental health treatments.

Alimera's partner files for approval of eye implant therapy Iluvien in Switzerland

(marketscreener.com) BOLINGBROOK, Ill., Dec. 14, 2022 /PRNewswire/ -- ATI Physical Therapy, Inc.  , the largest single-branded outpatient physical therapy provider in the United States, today announced that healthcare operations veteran Christopher Cox will join ATI as its new Chief Operating Officer beginning Dec. 16. Cox has more than 17 years'...https//www.marketscreener.com/quote/stock/ATI-PHYSICAL-THERAPY-INC-113213018/news/ATI-Physical-Therapy-Announces-Healthcare-Operations-Veteran-Chris-Cox-as-Chief-Operating-Officer-42549509/?utm_medium=RSS&utm_content=20221214

Participants used words like ‘traumatising’, ‘destructive’ and ‘horrendous’ to describe their experiences.